Synopsis:
Ajooni Biotech jumped sharply after it bagged an order price Rs 25 Crore from India’s high Dairy Provider. It additionally gave a key replace on launching its one other facility with an annual output of 1,20,000 MT of cattle feed.
The shares of this main animal well being care options firm are in focus because it bagged a prestigious order. On this article, we are going to dive into the small print of this order bagged by the corporate.
With a market capitalization of Rs 99.2 crore, the shares of Ajooni Biotech Ltd made a day excessive of Rs 5.94 per share, up by 17 % from its earlier day closing value of Rs 5.08 per share. Within the final one yr, the inventory has corrected by over 25 %.
Concerning the order
Ajooni Biotech, by means of a inventory alternate submitting, introduced that it has landed a significant order price Rs 25 crore from one in every of India’s high dairy cooperatives for its premium cattle feed. This order from a loyal buyer actually underscores the boldness in Ajooni’s merchandise, that are crafted to spice up livestock well being and enhance milk manufacturing.
Moreover, the corporate additionally introduced that it’s gearing as much as operationalise its cutting-edge manufacturing facility by November 2025, aiming for a formidable annual output of 1,20,000 MT of cattle feed. With state-of-the-art expertise in place, this new plant is about to boost operational effectivity, scale back manufacturing prices, and drive vital income development.
Additionally learn: Actual property inventory in focus after it acquires ₹6.44 Cr land in Mumbai to broaden Ambavat Bhavan venture
Monetary Highlights
The corporate’s income for Q1 FY26 was Rs 31.27 crore, representing a 22 % enhance from Rs 25.66 crore in the identical quarter final yr. Moreover, on a sequential foundation, income elevated by 7 % from Rs 29.27 crore in This autumn FY25.
Relating to its profitability, the corporate reported a 66 % web revenue development to Rs 78 lakh in Q1 FY26, in comparison with Rs 47 lakh in Q1 FY25. Nonetheless, on a QoQ foundation, it declined by 49 % from Rs 1.54 crore.
The inventory delivered a poor ROE and ROCE of 5.15 % and 6.19 % respectively, and is at the moment buying and selling at a excessive P/E of 27x as in comparison with its trade common of 18.57x.
Ajooni Biotech Restricted is an animal healthcare firm primarily based in India, specializing in creating specialised compounded animal feed and dietary supplements. They provide a spread of cattle feeds, together with calf starter, dairy calf grower, and high-yield cattle feed, all marketed underneath manufacturers like Autus DIAMOND WONDER, Autus WINNER, and Autus ENERGY PLUS.
Moreover, the corporate gives varied feed dietary supplements akin to liquid calcium, liver tonic, mineral mixtures, digestive powders, and multivitamins, branded as CALTUS, LIVTUS, RUMITUS, Mustmin, and AUTOVITA.
Written by Satyajeet Mukherjee
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of monetary losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Personal Restricted or the creator are usually not responsible for any losses triggered on account of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
